These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 22972524

  • 1. Long-term durability of the response to desmopressin in female and male nocturia patients.
    Juul KV, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524
    [Abstract] [Full Text] [Related]

  • 2. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O, Nishizawa O, Juul KV, Nørgaard JP.
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK, Dmochowski RR, Reddy J, van der Meulen EA.
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP, Herschorn S, Albei CD, van der Meulen EA.
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [Abstract] [Full Text] [Related]

  • 5. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP, Zinner NR, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [Abstract] [Full Text] [Related]

  • 6. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP.
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [Abstract] [Full Text] [Related]

  • 7. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria.
    Weiss JP, van der Meulen EA, Juul KV.
    Eur Urol Focus; 2020 Sep 15; 6(5):1006-1012. PubMed ID: 30470646
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program.
    Yamaguchi O, Juul KV, Falahati A, Yoshimura T, Imura F, Kitamura M.
    Low Urin Tract Symptoms; 2020 Jan 15; 12(1):8-19. PubMed ID: 31397969
    [Abstract] [Full Text] [Related]

  • 9. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
    Fu FG, Lavery HJ, Wu DL.
    Neurourol Urodyn; 2011 Mar 15; 30(3):312-6. PubMed ID: 21305590
    [Abstract] [Full Text] [Related]

  • 10. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES, Raymond K, Andruczyk E, Juul KV.
    Low Urin Tract Symptoms; 2018 Sep 15; 10(3):221-230. PubMed ID: 28560762
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
    Hvistendahl GM, Riis A, Nørgaard JP, Djurhuus JC.
    BJU Int; 2005 Apr 15; 95(6):804-9. PubMed ID: 15794787
    [Abstract] [Full Text] [Related]

  • 12. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ, Stokes A, Turner KL.
    J Urol; 1997 Sep 15; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of desmopressin in women with nocturia: a systematic review and meta-analysis of randomized controlled trials.
    Cai X, Tian Y, Nie M, Wang K.
    Int Urol Nephrol; 2019 Nov 15; 51(11):1913-1923. PubMed ID: 31352583
    [Abstract] [Full Text] [Related]

  • 14. Desmopressin for treating nocturia in men.
    Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.
    Cochrane Database Syst Rev; 2017 Oct 21; 10(10):CD012059. PubMed ID: 29055129
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women.
    Lose G, Lalos O, Freeman RM, van Kerrebroeck P, Nocturia Study Group.
    Am J Obstet Gynecol; 2003 Oct 21; 189(4):1106-13. PubMed ID: 14586363
    [Abstract] [Full Text] [Related]

  • 16. Gender difference in antidiuretic response to desmopressin.
    Juul KV, Klein BM, Sandström R, Erichsen L, Nørgaard JP.
    Am J Physiol Renal Physiol; 2011 May 21; 300(5):F1116-22. PubMed ID: 21367921
    [Abstract] [Full Text] [Related]

  • 17. Clinical experiences with desmopressin for long-term treatment of nocturia.
    Lose G, Mattiasson A, Walter S, Lalos O, van Kerrebroeck P, Abrams P, Freeman R.
    J Urol; 2004 Sep 21; 172(3):1021-5. PubMed ID: 15311028
    [Abstract] [Full Text] [Related]

  • 18. Achieving clinically meaningful quality of life benefits in nocturia takes time: Results from a long-term, multicenter phase 3 study of desmopressin in Japanese patients.
    Juul KV, Andersson FL, Yamaguchi O.
    Low Urin Tract Symptoms; 2021 Jan 21; 13(1):129-138. PubMed ID: 32914581
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men.
    Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J.
    BJU Int; 2002 Jun 21; 89(9):855-62. PubMed ID: 12010228
    [Abstract] [Full Text] [Related]

  • 20. Desmopressin for treating nocturia in men.
    Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.
    BJU Int; 2018 Oct 21; 122(4):549-559. PubMed ID: 29489052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.